Comparison of Two Ventilation Methods for Micro-Laryngeal Surgery

NCT ID: NCT04369040

Last Updated: 2025-04-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

3 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-03-10

Study Completion Date

2022-07-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Single-center, randomized study, comparing two methods of oxygenation on 80 patients

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is a single-center, randomized study, comparing two methods of oxygenation during micro-laryngeal surgery performed under general anesthesia and myorelaxation: high-flow nasal oxygen therapy (HFNO) or Flow Controlled Ventilation (FCV) using a laryngeal tri-tube. The study population will be composed of 80 patients, aged over 18 and under 80.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Laryngeal Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

High-flow nasal oxygen therapy

Ventilation with High-flow nasal oxygen therapy

Group Type OTHER

High-flow nasal oxygen therapy using a specific nasal cannula

Intervention Type DEVICE

Patient in this arm will received high-flow nasal oxygen therapy ventilation during the ENT surgery

Flow Controlled Ventilation

Ventilation with laryngeal tri-tube with Flow Controlled Ventilation technique

Group Type EXPERIMENTAL

Flow Controlled Ventilation using a laryngeal tri-tube

Intervention Type DEVICE

Patient in this arm will received a laryngeal tri-tube ventilation during the ENT surgery

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

High-flow nasal oxygen therapy using a specific nasal cannula

Patient in this arm will received high-flow nasal oxygen therapy ventilation during the ENT surgery

Intervention Type DEVICE

Flow Controlled Ventilation using a laryngeal tri-tube

Patient in this arm will received a laryngeal tri-tube ventilation during the ENT surgery

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient over the age of 18 and under the age of 80
* Patient to benefit from micro-laryngeal ENT surgery under general anesthesia and myorelaxation with an estimated duration which does not exceed 30 minutes
* Having signed a consent form
* Being affiliated with a Health Insurance plan.

Exclusion Criteria

* Pregnant or lactating patient
* Patient with a weight \<40 kg
* Obese patient (BMI\> 30)
* Patient with foreseeable intubation difficulty
* Patient maintained under general anesthesia postoperatively
* Surgery requiring time by surgical laser
* Surgery involving the use of an active electrosurgical electrode in the immediate area of the electrosurgical device or electrode
* Predictable surgery longer than 30 minutes
* Being deprived of liberty or under guardianship.
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hopital Foch

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Morgan Le Guen, Dr

Role: PRINCIPAL_INVESTIGATOR

Hopital Foch

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hopital Foch

Suresnes, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2020_0016

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.